Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, September 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 265 articles:
HTML format


 

Single Articles

  1. ALIE MS, Negesse Y, Ayenew M
    Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis.
    Cancer Control. 2023;30:10732748231195681.
    PubMed    
    Abstract available

  2. KENTER GG, Greggi S, Vergote I, Katsaros D, et al
    Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
    J Clin Oncol. 2023 Sep 1:JCO2202852. doi: 10.1200/JCO.22.02852.
    PubMed    
    Abstract available

  3. YUAN Y, Liu X, Yin C, Shi L, et al
    Cognitive behavioral stress management is an effective intervention to relieve anxiety and depression, improve the quality of life in patients with cervical cancer.
    Ir J Med Sci. 2023 Sep 1. doi: 10.1007/s11845-023-03501.
    PubMed    
    Abstract available

  4. GHAI I, Wagner GJ, Matovu JKB, Juncker M, et al
    Increased Knowledge Mediates the Effect of Game Changers for Cervical Cancer Prevention on Diffusion of Cervical Cancer Screening Advocacy Among Social Network Members in a Pilot Trial.
    Int J Behav Med. 2023 Sep 1. doi: 10.1007/s12529-023-10217.
    PubMed    
    Abstract available

  5. FUZZELL L, Brownstein NC, Fontenot HB, Lake PW, et al
    Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
    Elife. 2023;12:e85682.
    PubMed    
    Abstract available

  6. AI C, Zhang L, Ding W, Zhong S, et al
    A nomogram-based optimized Radscore for preoperative prediction of lymph node metastasis in patients with cervical cancer after neoadjuvant chemotherapy.
    Front Oncol. 2023;13:1117339.
    PubMed    
    Abstract available

  7. MOU J, Zheng W, Wei D, Li D, et al
    CD200-CD200R affects cisplatin and paclitaxel sensitivity by regulating cathepsin K-mediated p65 NF-kappaB signaling in cervical cancer.
    Heliyon. 2023;9:e19220.
    PubMed    
    Abstract available

  8. LEE SW, Kim A, Lee SJ, Kim SH, et al
    Intensity-Modulated Radiation Therapy (IMRT) for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy - an Option or a Must?: A Narrative Review.
    Cancer Res Treat. 2023 Aug 30. doi: 10.4143/crt.2023.
    PubMed    
    Abstract available

  9. WAGNER GJ, Matovu JKB, Juncker M, Namisango E, et al
    Correlates of cervical cancer prevention advocacy and cervical cancer screening in Uganda: Cross-sectional evaluation of a conceptual model.
    Medicine (Baltimore). 2023;102:e34888.
    PubMed    
    Abstract available

  10. ZHANG N, Pang C, Li Z, Xu F, et al
    Serum CXCL8 and CXCR2 as diagnostic biomarkers for noninvasive screening of cervical cancer.
    Medicine (Baltimore). 2023;102:e34977.
    PubMed    
    Abstract available

  11. LABAN M, Chen X, Guo B
    Unmasking the Hypoxia Landscape in Cervical Cancer: S100A2 and Its Implication for Immunotherapy Resistance.
    Reprod Sci. 2023 Aug 31. doi: 10.1007/s43032-023-01336.
    PubMed    
    Abstract available

  12. DOVER L, Dulaney C
    Spine Stereotactic Radiosurgery, Prostate Radiation Frequency, Adjuvant Chemotherapy for Cervical Cancer, Bacteria and Radiation Dermatitis, and Breast Conservation Therapy for Multifocal Disease.
    Pract Radiat Oncol. 2023;13:379-383.
    PubMed    


  13. ROMANOVA M, Zidlik V, Javurkova V, Konde A, et al
    L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer.
    In Vivo. 2023;37:2334-2339.
    PubMed    
    Abstract available

  14. CENCI M, Rossi F, Pisani T
    Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening.
    In Vivo. 2023;37:2161-2165.
    PubMed    
    Abstract available

  15. OSEI EA, Ali Bakkari M, Boateng SA, Acquah A, et al
    Perceptions and attitudes toward partners support for cervical cancer screening among married men in Ghana.
    Public Health. 2023;223:139-144.
    PubMed    
    Abstract available

  16. VERGOTE I, Van Nieuwenhuysen E, O'Cearbhaill RE, Westermann A, et al
    Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
    J Clin Oncol. 2023 Aug 31:JCO2300720. doi: 10.1200/JCO.23.00720.
    PubMed    
    Abstract available

  17. WANG H, Luo S, Wu X, Ruan Y, et al
    Exploration of glycosyltransferases mutation status in cervical cancer reveals PARP14 as a potential prognostic marker.
    Glycoconj J. 2023 Aug 31. doi: 10.1007/s10719-023-10134.
    PubMed    
    Abstract available

  18. BOISEN M, Guido R
    Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer.
    Clin Obstet Gynecol. 2023;66:500-515.
    PubMed    
    Abstract available

  19. GUIDO R, Perkins RB
    Management of Abnormal Cervical Cancer Screening Test: A Risk-based Approach.
    Clin Obstet Gynecol. 2023;66:478-499.
    PubMed    
    Abstract available

  20. CLARKE MA
    HPV Testing and its Role in Cervical Cancer Screening.
    Clin Obstet Gynecol. 2023;66:448-469.
    PubMed    
    Abstract available

  21. GUIDO R
    Foreword: Contemporary Recommendations for Cervical Cancer and Anal Cancer Screening and Prevention.
    Clin Obstet Gynecol. 2023;66:431-432.
    PubMed    



  22. Contributors: Contemporary Recommendations for Cervical Cancer and Anal Cancer Screening and Prevention.
    Clin Obstet Gynecol. 2023;66:vi.
    PubMed    


  23. MCMULLAN JC, Rainey L, Morgan D, Johnston L, et al
    The effect of COVID-19 on the cervical screening programme within a Northern Irish Health and Social care trust.
    Ulster Med J. 2023;92:84-88.
    PubMed    
    Abstract available

  24. YANG J, Wan S, Zhao M, Cai H, et al
    Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer.
    Reprod Sci. 2023 Aug 30. doi: 10.1007/s43032-023-01304.
    PubMed    
    Abstract available

  25. KODAMA K, Tateishi C, Oda T, Cui L, et al
    Development of novel tracers for sentinel node identification in cervical cancer.
    Cancer Sci. 2023 Aug 30. doi: 10.1111/cas.15927.
    PubMed    
    Abstract available

  26. YIN S, Cui H, Qin S, Yu S, et al
    Manipulating TGF-beta signaling to optimize immunotherapy for cervical cancer.
    Biomed Pharmacother. 2023;166:115355.
    PubMed    
    Abstract available

  27. RICHARDSON MT, Attwood K, Smith G, Liang SY, et al
    Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey.
    Cancer Control. 2023;30:10732748231182795.
    PubMed    
    Abstract available

  28. LI Y, Wang C, Ma A, Rani AQ, et al
    Identification of HPV oncogene and host cell differentiation associated cellular heterogeneity in cervical cancer via single-cell transcriptomic analysis.
    bioRxiv. 2023 Aug 14:2023.08.10.552878. doi: 10.1101/2023.08.10.552878.
    PubMed    
    Abstract available

  29. DESSIE TM, Kassaw AT, Alen GD
    Determinants of precancerous cervical lesion among HIV infected women on ART in Woldia comprehensive specialized hospital NorthEast Ethiopia.
    BMC Womens Health. 2023;23:458.
    PubMed    
    Abstract available

  30. OUANHNON L, Bugat MR, Druel V, Grosclaude P, et al
    Link between the referring physician and breast and cervical cancers screening: a cross-sectional study in France.
    BMC Prim Care. 2023;24:167.
    PubMed    
    Abstract available

  31. DING Y, Fu T, Zhou W, Zhang X, et al
    Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report.
    Hum Vaccin Immunother. 2023;19:2252252.
    PubMed    
    Abstract available

  32. MCCORMICK LJ, Gutreuter S, Adeoye O, Alger SX, et al
    Cervical cancer screening positivity among women living with HIV in CDC-PEPFAR programs 2018-2022.
    J Acquir Immune Defic Syndr. 2023 Aug 23. doi: 10.1097/QAI.0000000000003286.
    PubMed    
    Abstract available

  33. ZOU R, Gu R, Tu X, Chen J, et al
    Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism.
    Discov Oncol. 2023;14:162.
    PubMed    
    Abstract available

  34. GOES EF, Guimaraes JMN, Almeida MDCC, Gabrielli L, et al
    The intersection of race/ethnicity and socioeconomic status: inequalities in breast and cervical cancer mortality in 20,665,005 adult women from the 100 Million Brazilian Cohort.
    Ethn Health. 2023 Aug 29:1-16. doi: 10.1080/13557858.2023.2245183.
    PubMed    
    Abstract available

  35. ARECHKIK A, Lahlou L, Kharbach A, Baba MA, et al
    Awareness, Knowledge and Attitude Regarding Cervical Cancer among Women Living with HIV in the Souss-Massa Region, Southern Morocco: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2023;24:2875-2884.
    PubMed    
    Abstract available

  36. DHANI FK, Daryanto B, Seputra KP
    Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Asian Pac J Cancer Prev. 2023;24:2641-2646.
    PubMed    
    Abstract available

  37. SANGRAJRANG S, Pitakkarnkul S, Muwonge R, Ploysawang P, et al
    Agreement between Self- and Physician?Sampling for Detection of High?Risk Human Papillomavirus Infections in Women Attending Cervical Screening at National Cancer Institute, Thailand.
    Asian Pac J Cancer Prev. 2023;24:2615-2619.
    PubMed    
    Abstract available

  38. WANG J, Wu Y, Zhang W, Chen Y, et al
    Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
    Radiat Oncol. 2023;18:142.
    PubMed    
    Abstract available

  39. BARBERA F, Frassine F, Volpi G, Ghedi B, et al
    Locally advanced cervical cancer: how the improvement in techniques in external beam radiotherapy and brachytherapy impacts on survival outcomes and long-term toxicities.
    Radiol Med. 2023 Aug 28. doi: 10.1007/s11547-023-01705.
    PubMed    
    Abstract available

  40. WU S, Liu L, Xu H, Zhu Q, et al
    The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer.
    Cancer Biol Ther. 2023;24:2249174.
    PubMed    
    Abstract available

  41. HASAN MUJAHID M, Upadhyay TK, Upadhye V, Sharangi AB, et al
    Phytocompound identification of aqueous Zingiber officinale rhizome (ZOME) extract reveals antiproliferative and reactive oxygen species mediated apoptotic induction within cervical cancer cells: an in vitro and in silico approach.
    J Biomol Struct Dyn. 2023 Aug 28:1-28. doi: 10.1080/07391102.2023.2247089.
    PubMed    
    Abstract available

  42. LI Y, Wang C, Ma A, Rani AQ, et al
    Identification of HPV oncogene and host cell differentiation associated cellular heterogeneity in cervical cancer via single-cell transcriptomic analysis.
    J Med Virol. 2023;95:e29060.
    PubMed    
    Abstract available

  43. DING N, Qi W, Wu Z, Zhang Y, et al
    Development of Enzymatic Recombinase Amplification Assays for the Rapid Visual Detection of HPV16/18.
    J Microbiol Biotechnol. 2023;33:1091-1100.
    PubMed    
    Abstract available

  44. MOTSA MPS, Estinfort W, Phiri YVA, Simelane MS, et al
    Body mass index and cervical cancer screening among women aged 15-69 years in Eswatini: evidence from a population-based survey.
    BMC Public Health. 2023;23:1638.
    PubMed    
    Abstract available

  45. PREM K, Choi YH, Benard E, Burger EA, et al
    Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
    BMC Med. 2023;21:313.
    PubMed    
    Abstract available

  46. WANG F, Wang X, Shi Y, Li L, et al
    Development of a risk nomogram predicting urinary tract infection in patients with indwelling urinary catheter after radical surgery for cervical cancer.
    Prog Urol. 2023 Aug 25:S1166-7087(23)00169-0. doi: 10.1016/j.purol.2023.
    PubMed    
    Abstract available

  47. ARBYN M, Cuschieri K, Poljak M, Bonde J, et al
    Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
    Clin Microbiol Infect. 2023 Aug 25:S1198-743X(23)00403.
    PubMed    


  48. GUPTA MK, Kushwah AS, Singh R, Srivastava K, et al
    Genetic and epigenetic alterations in MGMT gene and correlation with concomitant chemoradiotherapy (CRT) in cervical cancer.
    J Cancer Res Clin Oncol. 2023 Aug 27. doi: 10.1007/s00432-023-05305.
    PubMed    
    Abstract available

  49. OGUNSOLA OO, Ajayi OA, Ojo TO, Osayi E, et al
    Cervical cancer screening and treatment for PLWHIV: experiences from an innovative program in Nigeria.
    Reprod Health. 2023;20:125.
    PubMed    
    Abstract available

  50. SOWA I, Moldoch J, Paduch R, Strzemski M, et al
    Polyphenolic Composition of Carlina acaulis L. Extract and Cytotoxic Potential against Colorectal Adenocarcinoma and Cervical Cancer Cells.
    Molecules. 2023;28:6148.
    PubMed    
    Abstract available

  51. SINGH D, Desai N, Shah V, Datta B, et al
    In Silico Identification of Potential Quadruplex Forming Sequences in LncRNAs of Cervical Cancer.
    Int J Mol Sci. 2023;24:12658.
    PubMed    
    Abstract available

  52. RAYNER M, Welp A, Stoler MH, Cantrell LA, et al
    Cervical Cancer Screening Recommendations: Now and for the Future.
    Healthcare (Basel). 2023;11:2273.
    PubMed    
    Abstract available

  53. RUNGKAMOLTIP P, Roytrakul S, Navakanitworakul R
    MALDI-TOF MS Analysis of Serum Peptidome Patterns in Cervical Cancer.
    Biomedicines. 2023;11:2327.
    PubMed    
    Abstract available

  54. LIZCANO-MENESES S, Hernandez-Pando R, Garcia-Aguirre I, Bonilla-Delgado J, et al
    Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer.
    Biomedicines. 2023;11:2280.
    PubMed    
    Abstract available

  55. LIU P, Liu Z, Luo Q, Fu Q, et al
    A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer.
    Sci Rep. 2023;13:13898.
    PubMed    
    Abstract available

  56. POURROOSTAEI ARDAKANI P, Abkhiz S, Sheykhi K, Adhami Mojarad K, et al
    Molecular Investigation of the Association Among Common Interleukin-6 Polymorphism and Human Papillomavirus Genotypes with Cervical Cancer Among Iranian Women.
    Monoclon Antib Immunodiagn Immunother. 2023;42:125-131.
    PubMed    
    Abstract available

  57. SUN W, Chen X, Fu S, Huang X, et al
    Feasibility of Sentinel Lymph Node Mapping With Carbon Nanoparticles in Cervical Cancer: A Retrospective Study.
    Cancer Control. 2023;30:10732748231195716.
    PubMed    
    Abstract available

  58. FERIOLI M, Benini A, Malizia C, Forlani L, et al
    Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study).
    J Pers Med. 2023;13:1229.
    PubMed    
    Abstract available

  59. BECERRA-BOLANOS A, Jimenez-Gil M, Federico M, Dominguez-Diaz Y, et al
    Pain in High-Dose-Rate Brachytherapy for Cervical Cancer: A Retrospective Cohort Study.
    J Pers Med. 2023;13:1187.
    PubMed    
    Abstract available

  60. BARTL T, Grimm C, Mader RM, Zielinski C, et al
    Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer.
    J Pers Med. 2023;13:1186.
    PubMed    
    Abstract available

  61. NYABIGAMBO A, Mayega RW, Ginindza TG
    Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
    Int J Environ Res Public Health. 2023;20:6613.
    PubMed    
    Abstract available

  62. SMAYDA LC, Day GM, Redwood DG, Beans JA, et al
    Cancer Screening Prevalence among Participants in the Southcentral Alaska Education and Research towards Health (EARTH) Study at Baseline and Follow-Up.
    Int J Environ Res Public Health. 2023;20:6596.
    PubMed    
    Abstract available

  63. RAVEINTHIRANATHAN N, Simkin J, Donken R, Ogilvie G, et al
    Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971-2017.
    Curr Oncol. 2023;30:7692-7705.
    PubMed    
    Abstract available

  64. ELIT L, Tum EM, Ngalla C, Fungchwi GM, et al
    Perceptions of Cancer in Parents of Adolescent Daughters in Northwest Cameroon.
    Curr Oncol. 2023;30:7167-7177.
    PubMed    
    Abstract available

  65. WANG M, Jin Y, Zheng ZJ
    The association of cervical cancer screening and quality of care: A systematic analysis of the Global Burden of Disease Study 2019.
    J Glob Health. 2023;13:04090.
    PubMed    
    Abstract available

  66. MERTENS RC, Sykes PH, Innes CR, Simcock BJ, et al
    Endometrial cancer diagnoses prompted by routine cervical cytology: a retrospective case study.
    N Z Med J. 2023;136:56-65.
    PubMed    
    Abstract available

  67. MORI S, Ishii Y, Takeuchi T, Kukimoto I, et al
    Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
    J Virol. 2023;97:e0081523.
    PubMed    
    Abstract available

  68. CHEN B, Zhao L, Yang R, Xu T, et al
    Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
    Arch Biochem Biophys. 2023;745:109716.
    PubMed    
    Abstract available

  69. DAVID A, Julia M, David H, Serge M, et al
    Epidemiological profile of cancer at the laboratory of anatomy and pathological cytology of mungbere in the Democratic Republic of Congo.
    J Cancer Policy. 2023;37:100434.
    PubMed    
    Abstract available

  70. KHAN A, Han S, Ilyas N, Lee YM, et al
    CervixFormer: A Multi-scale swin transformer-Based cervical pap-Smear WSI classification framework.
    Comput Methods Programs Biomed. 2023;240:107718.
    PubMed    
    Abstract available

  71. MISHRA R, Pandey A, Mishra H, Singh S, et al
    Survival outcome and prognostic factors post inadvertent hysterectomy in carcinoma cervix treated with salvage chemo-radiation.
    J Cancer Res Clin Oncol. 2023;149:12355-12364.
    PubMed    
    Abstract available

  72. WINTERS AN, Berry AK, Dewenter TA, Chowdhury NU, et al
    MicroRNA expression associated with low-grade cervical intraepithelial neoplasia outcomes.
    J Cancer Res Clin Oncol. 2023;149:11969-11978.
    PubMed    
    Abstract available

  73. RIBEIRO AG, Ferlay J, Vaccarella S, Latorre MDRDO, et al
    Cancer inequalities in incidence and mortality in the State of Sao Paulo, Brazil 2001-17.
    Cancer Med. 2023;12:16615-16625.
    PubMed    
    Abstract available

  74. GOPALANI SV, Dasari SR, Adam EE, Thompson TD, et al
    Variation in hysterectomy prevalence and trends among U.S. States and Territories-Behavioral Risk Factor Surveillance System, 2012-2020.
    Cancer Causes Control. 2023;34:829-835.
    PubMed    
    Abstract available

  75. MISHRA SI, Adsul P, Leekity S, Rodman J, et al
    A culturally informed model to enhance breast, cervical, and colorectal cancer screenings: perspectives of American Indian adults and healthcare providers in rural New Mexico.
    Cancer Causes Control. 2023;34:855-871.
    PubMed    
    Abstract available

  76. ZENG Z, Wang W, Liu X, Wang G, et al
    Optimal cisplatin cycles in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapy.
    Clin Transl Oncol. 2023;25:2892-2900.
    PubMed    
    Abstract available

  77. COX E
    Performing HeLa: theatrical bodies and living remains.
    Med Humanit. 2023;49:447-456.
    PubMed    
    Abstract available

  78. SHIGA T, Taguchi A, Mori M, Yamaguchi S, et al
    Risk stratification of invasive cervical cancer diagnosed after cervical conization.
    Jpn J Clin Oncol. 2023 Sep 7:hyad121. doi: 10.1093.
    PubMed    
    Abstract available

  79. WEN Y, Liang H, Zhang H
    Clinical utility of HPV typing and quantification combined with PAX1/ZNF582 methylation detection in accurate cervical cancer screening.
    Cytojournal. 2023;20:26.
    PubMed    
    Abstract available

  80. GU L, Feng C, Li M, Hong Z, et al
    Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: a preliminary study.
    Eur J Med Res. 2023;28:323.
    PubMed    
    Abstract available

  81. BEDUK ESEN CS, Gedik ME, Canpinar H, Yedekci FY, et al
    Radiosensitising Effects of Metformin Added to Concomitant Chemoradiotherapy with Cisplatin in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2023 Sep 3:S0936-6555(23)00296.
    PubMed    
    Abstract available

  82. DA SILVA IF, da Silva IF, Saraceni V, Koifman RJ, et al
    Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country.
    Cancer Epidemiol. 2023;86:102450.
    PubMed    
    Abstract available

  83. BACORRO W, Baldivia K, Mariano J, Dancel E, et al
    Patient Decision Aid for Chemotherapy or Exclusion in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer: Development, Alpha Testing, and Peer Validation.
    JCO Glob Oncol. 2023;9:e2300096.
    PubMed    
    Abstract available

  84. DIO CD, Azenkoud I, Trezza A, Lentini E, et al
    Early-stage cervical cancer treatment - what's new?
    Prz Menopauzalny. 2023;22:87-92.
    PubMed    
    Abstract available

  85. MORSE R, Brown J, Lopez EJR, Prieto BA, et al
    Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention in Iquitos, Peru: a mixed methods study.
    Res Sq. 2023 Aug 23:rs.3.rs-3210614. doi: 10.21203/rs.3.rs-3210614.
    PubMed    
    Abstract available

  86. SHAHNAZ S, Fricovsky E, Anwar R, Arain MI, et al
    Cervical Cancer Awareness and Attitude Towards Cervical Cancer Screening and Human Papillomavirus Vaccines Among Urban Women of Karachi, Pakistan.
    Cureus. 2023;15:e42970.
    PubMed    
    Abstract available

  87. KONG L, Wang L, Wang Z, Xiao X, et al
    Cytological DNA methylation for cervical cancer screening: a validation set.
    Front Oncol. 2023;13:1181982.
    PubMed    
    Abstract available

  88. SUN YH, Chen LJ, Wang CH, Lee CY, et al
    Impact of LINC00673 genetic variants on uterine cervical cancer clinicopathologic characteristics.
    J Cancer. 2023;14:2529-2537.
    PubMed    
    Abstract available

  89. CHEN YQ
    [Dysplastic ichthyosis uteri-like changes of the entire endometrium associated with a high-grade squamous intraepithelial lesion of the uterine cervix: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2023;52:943-945.
    PubMed    


  90. DONG S, Zhang Y, Wang Y
    Role of extracellular vesicle in human papillomavirus-associated cervical cancer.
    J Cancer Res Clin Oncol. 2023 Sep 5. doi: 10.1007/s00432-023-05374.
    PubMed    
    Abstract available

  91. FENG Q, Cui N, Li S, Cao J, et al
    Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/beta-catenin signaling pathway.
    FASEB J. 2023;37:e23174.
    PubMed    
    Abstract available

  92. MARTELL K, McIntyre JB, Abedin T, Kornaga EN, et al
    Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated AKT Expression in Patients With Cervical Cancer Treated With Primary Surgery.
    Int J Gynecol Pathol. 2023 Aug 25. doi: 10.1097/PGP.0000000000000978.
    PubMed    
    Abstract available

  93. PHAN NTH, Tran QT, Nguyen NPT, Nguyen HT, et al
    Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium.
    J Gynecol Oncol. 2023;34:e88.
    PubMed    


  94. SCHOLL S, Roufai DB, Cherif LL, Kamal M, et al
    RAIDS atlas of significant genetic and protein biomarkers in cervical cancer.
    J Gynecol Oncol. 2023;34:e74.
    PubMed    
    Abstract available

  95. DE MUZIO F, Fusco R, Simonetti I, Grassi F, et al
    Functional assessment in endometrial and cervical cancer: diffusion and perfusion, two captivating tools for radiologists.
    Eur Rev Med Pharmacol Sci. 2023;27:7793-7810.
    PubMed    
    Abstract available

  96. HIDESHIMA M, Hashiguchi M, Honda A, Umezaki Y, et al
    Are HPV-negative lesions concerned for the introduction of primary HPV testing for cervical cancer screening in Japan?
    J Obstet Gynaecol Res. 2023 Sep 4. doi: 10.1111/jog.15784.
    PubMed    
    Abstract available

  97. GONG Z, Ge L, Ye S, Xu Y, et al
    Hsa_circ_0000069 Accelerates Cervical Cancer Progression by Sponging miR-1270 to Facilitate CPEB4 Expression.
    Biochem Genet. 2023 Sep 4. doi: 10.1007/s10528-023-10494.
    PubMed    
    Abstract available

  98. FENG S, Zhao J, Yang T, Li L, et al
    TMPRSS11D/ALR-mediated ER stress regulates the function of myeloid-derived suppressor cells in the cervical cancer microenvironment.
    Int Immunopharmacol. 2023;124.
    PubMed    
    Abstract available

  99. ZHANG Y, Li X, Zhang J, Mao L, et al
    USF1 regulated circPRDM4 modulates tumorigenesis and immune escape in chemoresistant cervical cancer.
    J Cell Mol Med. 2023 Sep 4. doi: 10.1111/jcmm.17945.
    PubMed    
    Abstract available

  100. FUZZELL L, Lake P, Brownstein NC, Fontenot HB, et al
    Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
    Elife. 2023;12:e86358.
    PubMed    
    Abstract available

  101. LIU H, Xie T, Liu Y
    Ginsenoside Rg3 inhibits the malignant progression of cervical cancer cell by regulating AKT2 expression.
    Heliyon. 2023;9:e19045.
    PubMed    
    Abstract available

  102. TIAN W, Sun S, Wu B, Yu C, et al
    Development and validation of a deep learning algorithm for pattern-based classification system of cervical cancer from pathological sections.
    Heliyon. 2023;9:e19229.
    PubMed    
    Abstract available

  103. TENKIR L, Mamuye A, Jemebere W, Yeheyis T, et al
    The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study.
    Front Glob Womens Health. 2023;4:1187916.
    PubMed    
    Abstract available

  104. HUANG J, Zeng X, Chen H, Luo D, et al
    Clinical analysis of decision implementation by a multidisciplinary team in cervical cancer cases in Ganzhou, China.
    Front Oncol. 2023;13:1160626.
    PubMed    
    Abstract available

  105. ITANYI IU, Viglione C, Rositch AF, Olawepo JO, et al
    Rapid implementation mapping to identify implementation determinants and strategies for cervical cancer control in Nigeria.
    Front Public Health. 2023;11:1228434.
    PubMed    
    Abstract available

  106. SHRESTHA IB, Bhusal S, Rajbanshi M, Mali P, et al
    Awareness of Cervical Cancer, Risk Perception, and Practice of Pap Smear Test among Young Adult Women of Dhulikhel Municipality, Nepal.
    J Cancer Epidemiol. 2023;2023:6859054.
    PubMed    
    Abstract available

  107. RODRIGUEZ I, Rossi NM, Keskus A, Xie Y, et al
    Insights into the Mechanisms and Structure of Breakage-Fusion-Bridge Cycles in Cervical Cancer using Long-Read Sequencing.
    medRxiv. 2023 Aug 22:2023.08.21.23294276. doi: 10.1101/2023.08.21.23294276.
    PubMed    
    Abstract available

  108. PALMER M, Katanoda K, Saito E, Acuti Martellucci C, et al
    Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" [Vaccine 40(41) (2022) 5971-5996].
    Vaccine. 2023 Sep 1:S0264-410X(23)00787-9. doi: 10.1016/j.vaccine.2023.
    PubMed    


  109. WANG D, Wu S, He J, Sun L, et al
    FAT4 overexpression promotes antitumor immunity by regulating the beta-catenin/STT3/PD-L1 axis in cervical cancer.
    J Exp Clin Cancer Res. 2023;42:222.
    PubMed    
    Abstract available

  110. LAWSON O, Ameyan L, Tukur Z, Dunu S, et al
    Cervical cancer screening outcomes in public health facilities in three states in Nigeria.
    BMC Public Health. 2023;23:1688.
    PubMed    
    Abstract available

  111. BUDAK B, Kalin SN, Yapca OE
    Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep 1. doi: 10.1007/s00210-023-02698.
    PubMed    
    Abstract available

  112. XU H, Tian G, Wu C, Sun X, et al
    Meta-analysis of the efficacy and safety of Xihuang Pills/capsules in adjuvant treatment of uterine cervical neoplasms.
    Medicine (Baltimore). 2023;102:e34846.
    PubMed    
    Abstract available

  113. HEINIG M, Schafer W, Langner I, Zeeb H, et al
    German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis.
    BMC Public Health. 2023;23:1678.
    PubMed    
    Abstract available

  114. ENOMOTO T, Okamoto A, Kim JH, Lai CH, et al
    East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
    J Gynecol Oncol. 2023;34:e86.
    PubMed    
    Abstract available

  115. ZHANG W, Che Q, Tan H, Qi X, et al
    A novel antimycin analogue antimycin A2c, derived from marine Streptomyces sp., suppresses HeLa cells via disrupting mitochondrial function and depleting HPV oncoproteins E6/E7.
    Life Sci. 2023;330:121998.
    PubMed    
    Abstract available

  116. THAKUR K, Janjua D, Aggarwal N, Chhokar A, et al
    Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control.
    Biochim Biophys Acta Mol Basis Dis. 2023;1869:166817.
    PubMed    
    Abstract available

  117. ZHANG L, Ma J, Zhou D, Zhou J, et al
    Single-Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell Cancer Identifies Neural-Like Progenitor Program Associated with the Efficacy of Radiotherapy.
    Adv Sci (Weinh). 2023;10:e2300348.
    PubMed    
    Abstract available

  118. WANG L, Liu X, Zhang J, Li H, et al
    Comparison of ALA-PDT and CO(2) laser treatment of low-grade vaginal intraepithelial neoplasia with high-risk HPV infection: A non-randomized controlled pilot study.
    Photodiagnosis Photodyn Ther. 2023;43:103695.
    PubMed    
    Abstract available

  119. MUKHERJEE A, Ye Y, Wiener HW, Kuniholm MH, et al
    Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1190-1197.
    PubMed    
    Abstract available

  120. RECHT HS, Shampain KL, Flory MN, Nougaret S, et al
    Gynecologic oncology tumor board: the central role of the radiologist.
    Abdom Radiol (NY). 2023;48:3265-3279.
    PubMed    
    Abstract available

  121. ZHUANG Y, Yang H
    The significance of nonsurgical therapies for cervical infection of high-risk human papilloma virus: A systematic review and meta-analysis.
    J Obstet Gynaecol Res. 2023;49:2213-2231.
    PubMed    
    Abstract available

  122. KOBORI T, Ito Y, Doukuni R, Urashima Y, et al
    Radixin modulates the plasma membrane localization of CD47 in human uterine cervical adenocarcinoma cells.
    J Reprod Immunol. 2023;158:103982.
    PubMed    
    Abstract available

  123. TANAKA M, Yamanoi K, Taki M, Kitamura S, et al
    High-grade vaginal intraepithelial neoplasia after hysterectomy for high-grade cervical intraepithelial neoplasia: Is hysterectomy a "definitive" treatment compared to conization?
    J Obstet Gynaecol Res. 2023;49:2361-2369.
    PubMed    
    Abstract available

  124. QUINTAL C, Antunes M
    Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
    Acta Med Port. 2023;36:577-587.
    PubMed    
    Abstract available

  125. PENG S, Zhang X, Wu Y
    Potential applications of DNA methylation testing technology in female tumors and screening methods.
    Biochim Biophys Acta Rev Cancer. 2023;1878:188941.
    PubMed    
    Abstract available

  126. HISAMATSU Y, Kita M, Yokoe T, Butsuhara Y, et al
    A pilot study of repeated 5-aminolevulinic acid photodynamic therapy for cervical intraepithelial neoplasia by a newly developed intravaginal irradiation system.
    Photodiagnosis Photodyn Ther. 2023;43:103655.
    PubMed    
    Abstract available

  127. FRANCO EL
    Homage to Georgios Papanikolaou: A pilgrimage to his birthplace.
    Cancer Cytopathol. 2023;131:546-547.
    PubMed    


  128. WELBY S, Feng Y, Tang H, Ye C, et al
    A feasibility assessment of real-world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case.
    Pharmacoepidemiol Drug Saf. 2023;32:1131-1141.
    PubMed    
    Abstract available

  129. YANG EJ, Lee AJ, So KA, Lee SJ, et al
    Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use.
    J Gynecol Oncol. 2023;34:e63.
    PubMed    
    Abstract available

  130. WU Y, Ying H, Wang J
    Myxoid leiomyosarcoma of the uterine cervix: A case report.
    Asian J Surg. 2023;46:3835-3836.
    PubMed    


  131. LIN X, Yoshikawa N, Liu W, Matsukawa T, et al
    DDIT4 Facilitates Lymph Node Metastasis via the Activation of NF-kappaB Pathway and Epithelial-Mesenchymal Transition.
    Reprod Sci. 2023;30:2829-2841.
    PubMed    
    Abstract available

  132. ZHANG M, Xin L, Cheng B, Yan B, et al
    Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical Cancer.
    Altern Ther Health Med. 2023 Sep 15:AT9130.
    PubMed    
    Abstract available

  133. LAWTON B, MacDonald EJ, Storey F, Stanton JA, et al
    A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover Trial.
    JMIR Res Protoc. 2023;12:e51643.
    PubMed    
    Abstract available

  134. SINGH G, Sharma SK, Dorata A, Singh SK, et al
    miR-17 ~ 92 suppresses proliferation and invasion of cervical cancer cells by inhibiting cell cycle regulator Cdt2.
    Discov Oncol. 2023;14:172.
    PubMed    
    Abstract available

  135. HAN Y, Wang X, Li X, Chen J, et al
    Analysis of clinicopathological features and prognosis of double primary cervical cancer and ovarian cancer based on SEER database.
    J Cancer Res Clin Oncol. 2023 Sep 14. doi: 10.1007/s00432-023-05373.
    PubMed    
    Abstract available

  136. IOVA CF, Badau D, Daina MD, Suteu CL, et al
    Evaluation of the Knowledge and Attitude of Adolescents Regarding the HPV Infection, HPV Vaccination and Cervical Cancer in a Region from the Northwest of Romania.
    Patient Prefer Adherence. 2023;17:2249-2262.
    PubMed    
    Abstract available

  137. CHU M, Ji H, Li K, Liu H, et al
    Investigating the potential mechanism of quercetin against cervical cancer.
    Discov Oncol. 2023;14:170.
    PubMed    
    Abstract available

  138. WAGNER GJ, Matovu JKB, Juncker M, Namisango E, et al
    Effects of a peer advocacy intervention on cervical cancer screening among social network members: results of a randomized controlled trial in Uganda.
    J Behav Med. 2023 Sep 13. doi: 10.1007/s10865-023-00418.
    PubMed    
    Abstract available

  139. DHILLON SK, Chung PYJ, Padalko E, Praet M, et al
    Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.
    J Med Virol. 2023;95:e29093.
    PubMed    
    Abstract available

  140. WANG M, Liu K, Zhou Z, Geng H, et al
    miR-638 suppresses cervical cancer progression by inhibiting NCAPG2 under the treatment of Tetrandrine.
    Histol Histopathol. 2023 Aug 4:18657. doi: 10.14670.
    PubMed    
    Abstract available

  141. HAN C, Huang W, Ye M, Zou R, et al
    HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China.
    Front Public Health. 2023;11:1225652.
    PubMed    
    Abstract available

  142. HUANG Z, Jing H, Lv J, Chen Y, et al
    Investigating Doxorubicin's mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives.
    Front Genet. 2023;14:1234263.
    PubMed    
    Abstract available

  143. SU X, Liu P, Zhao H, Sun L, et al
    Impact of HR-HPV infection on oncological outcomes in early cervical cancer.
    Front Oncol. 2023;13:1264114.
    PubMed    
    Abstract available

  144. KULTALAHTI H, Heinavaara S, Sarkeala T, Pankakoski M, et al
    Effect of Test History at Ages 50-64 on Later Cervical Cancer Risk: A Population-based Case-control Study.
    Cancer Res Commun. 2023;3:1823-1829.
    PubMed    
    Abstract available

  145. MIR BA, Ahmad A, Farooq N, Priya MV, et al
    Increased expression of HPV-E7 oncoprotein correlates with a reduced level of pRb proteins via high viral load in cervical cancer.
    Sci Rep. 2023;13:15075.
    PubMed    
    Abstract available

  146. LIU C, Ran X, Wang Z, Zhang K, et al
    Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.
    Chin Clin Oncol. 2023;12:38.
    PubMed    
    Abstract available

  147. MOHAMMADI ESFANJANI S, Aghebati Maleki L, Nami S, Ebrahimi M, et al
    Induction of TLR5, IRAK1, and NF-kappaB expression by Trichomonas vaginalis in cervical cancer cell (HeLa) and normal human vaginal epithelial cell (HVECs) lines.
    J Infect Dev Ctries. 2023;17:1160-1167.
    PubMed    
    Abstract available

  148. MURUGESAN B, Subramanian A, Bakthavachalam S, Rajendran K, et al
    Molecular insights of anticancer potential of usnic acid towards cervical cancer target proteins: An in silico validation for novel anti-cancer compound from lichens.
    J Biomol Struct Dyn. 2023 Sep 11:1-19. doi: 10.1080/07391102.2023.2252076.
    PubMed    
    Abstract available

  149. MAKONI M
    Africa reaffirms commitments to eliminate cervical cancer.
    Lancet Oncol. 2023 Sep 8:S1470-2045(23)00450.
    PubMed    


  150. MOZES N, Feith HJ
    [Comparative study of factors influencing cytological screening for cervical cancer attendance in Hungary among Roma and non-Roma population, in relation to Slovak and Romanian results].
    Orv Hetil. 2023;164:1416-1425.
    PubMed    
    Abstract available

  151. PU T, Jin Y, Tang C, Fu J, et al
    An innovative predictive model for cervical cancer constructed around a gene profile associated with cholesterol metabolism.
    Environ Toxicol. 2023 Sep 11. doi: 10.1002/tox.23969.
    PubMed    
    Abstract available

  152. GAO F, Yin J, Wang Y, Li H, et al
    miR-182 promotes cervical cancer progression via activating the Wnt/beta-catenin axis.
    Am J Cancer Res. 2023;13:3591-3598.
    PubMed    
    Abstract available

  153. ZHANG H, Wang X, Ma Y, Zhang Q, et al
    Review of possible mechanisms of radiotherapy resistance in cervical cancer.
    Front Oncol. 2023;13:1164985.
    PubMed    
    Abstract available

  154. HUANG S, Qi Y, Chen S, He B, et al
    Effect of heat-clearing and dampness-eliminating Chinese medicine for high-risk cervical cancer papillomavirus infection: a systematic review and meta-analysis of randomized controlled trials.
    Front Med (Lausanne). 2023;10:1022030.
    PubMed    
    Abstract available

  155. AKHLAQ A, Ashraf M, Omer MO, Altaf I, et al
    Carvacrol-Fabricated Chitosan Nanoparticle Synergistic Potential with Topoisomerase Inhibitors on Breast and Cervical Cancer Cells.
    ACS Omega. 2023;8:31826-31838.
    PubMed    
    Abstract available

  156. DAI B
    A Comparison of Colour Doppler Ultrasound and 2D Ultrasound as Promising Prediction Methods for the Treatment effect of Patients with Advanced Cervical Cancer.
    Curr Med Imaging. 2023 Sep 8. doi: 10.2174/1573405620666230908111722.
    PubMed    
    Abstract available

  157. ZUGHAIBI TA, Jabir NR, Khan AU, Khan MS, et al
    Screening of Cu(4) O(3) NPs efficacy and its anticancer potential against cervical cancer.
    Cell Biochem Funct. 2023 Sep 10. doi: 10.1002/cbf.3850.
    PubMed    
    Abstract available

  158. LEUNG SMK, Wu J, Chan KKL, Jit M, et al
    Maximising the cost-effectiveness of human papillomavirus testing for cervical screening in the context of routine HPV vaccination in Hong Kong: abridged secondary publication.
    Hong Kong Med J. 2023;29 Suppl 4:11-15.
    PubMed    


  159. SCHIVARDI G, Casarin J, Habermann EB, Bews KA, et al
    Practice patterns and complications of hysterectomy for invasive cervical cancer after the LACC trial.
    Am J Obstet Gynecol. 2023 Sep 8:S0002-9378(23)00608.
    PubMed    
    Abstract available

  160. LATUL YP, Ince C, van Trommel NE, van den Brandhof-van den Berg A, et al
    Handheld vital microscopy for the identification of microcirculatory alterations in cervical intraepithelial neoplasia and cervical cancer.
    Microvasc Res. 2023 Sep 8:104608. doi: 10.1016/j.mvr.2023.104608.
    PubMed    
    Abstract available

  161. LIU L, Wu M, Huang A, Gao C, et al
    Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
    J Transl Med. 2023;21:611.
    PubMed    
    Abstract available

  162. HAN S, Liu X, Ju S, Mu W, et al
    New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics.
    Clin Proteomics. 2023;20:35.
    PubMed    
    Abstract available

  163. JAAPAR FN, Parmin NA, Halim NHA, Hashim U, et al
    Micro-interdigitated electrodes genosensor based on Au-deposited nanoparticles for early detection of cervical cancer.
    Int J Biol Macromol. 2023;253.
    PubMed    
    Abstract available

  164. ONUKI M, Takahashi F, Iwata T, Nakazawa H, et al
    Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.
    Cancer Sci. 2023 Sep 8. doi: 10.1111/cas.15943.
    PubMed    
    Abstract available

  165. YANG Y, Liao Y, Qing Y, Li H, et al
    Electrochemical DNA Biosensors with Dual-Signal Amplification Strategy for Highly Sensitive HPV 16 Detection.
    Sensors (Basel). 2023;23:7380.
    PubMed    
    Abstract available

  166. KREGIELEWSKI K, Fraczek W, Grodzik M
    Graphene Oxide Enhanced Cisplatin Cytotoxic Effect in Glioblastoma and Cervical Cancer.
    Molecules. 2023;28:6253.
    PubMed    
    Abstract available

  167. KARAMTI H, Alharthi R, Anizi AA, Alhebshi RM, et al
    Improving Prediction of Cervical Cancer Using KNN Imputed SMOTE Features and Multi-Model Ensemble Learning Approach.
    Cancers (Basel). 2023;15:4412.
    PubMed    
    Abstract available

  168. MICHAAN N, Leshno M, Fire G, Safra T, et al
    Cost-Utility Analysis of Open Radical Hysterectomy Compared to Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
    Cancers (Basel). 2023;15:4325.
    PubMed    
    Abstract available

  169. CAKIR MO, Bilge U, Naughton D, Ashrafi GH, et al
    Ficus carica Latex Modulates Immunity-Linked Gene Expression in Human Papillomavirus Positive Cervical Cancer Cell Lines: Evidence from RNA Seq Transcriptome Analysis.
    Int J Mol Sci. 2023;24:13646.
    PubMed    
    Abstract available

  170. OKODO M, Okayama K, Sasagawa T, Teruya K, et al
    Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses.
    Int J Mol Sci. 2023;24:13151.
    PubMed    
    Abstract available

  171. BRUNO V, Chiofalo B, Logoteta A, Brandolino G, et al
    Urological Complications in Radical Surgery for Cervical Cancer: A Comparative Meta-Analysis before and after LACC Trial.
    J Clin Med. 2023;12:5677.
    PubMed    
    Abstract available

  172. SIMION L, Rotaru V, Cirimbei C, Gales L, et al
    Inequities in Screening and HPV Vaccination Programs and Their Impact on Cervical Cancer Statistics in Romania.
    Diagnostics (Basel). 2023;13:2776.
    PubMed    
    Abstract available

  173. ALSALATIE M, Alquran H, Mustafa WA, Zyout A, et al
    A New Weighted Deep Learning Feature Using Particle Swarm and Ant Lion Optimization for Cervical Cancer Diagnosis on Pap Smear Images.
    Diagnostics (Basel). 2023;13:2762.
    PubMed    
    Abstract available

  174. LI C, Chen L, Pan G, Zhang W, et al
    Deciphering complex breakage-fusion-bridge genome rearrangements with Ambigram.
    Nat Commun. 2023;14:5528.
    PubMed    
    Abstract available

  175. RAFFA S, Lanfranchi F, Satragno C, Giannelli F, et al
    The prognostic value of FIGO staging defined by combining MRI and [(18)F]FDG PET/CT in patients with locally advanced cervical cancer.
    Curr Probl Cancer. 2023 Sep 5:101007. doi: 10.1016/j.currproblcancer.2023.101007
    PubMed    
    Abstract available

  176. MARTINS LFL, Moreira MAM, Pinto RA, Reis NBD, et al
    Human Papillomavirus 16 Lineage D is Associated with High Risk of Cervical Cancer in the Brazilian Northeast Region.
    Rev Bras Ginecol Obstet. 2023;45:e474-e479.
    PubMed    
    Abstract available

  177. GE BB, Liu Y, Jin JH, Wu JT, et al
    Effect of bladder filling status on positioning errors in post-hysterectomy cervical cancer radiotherapy.
    Ann Med. 2023;55:2249936.
    PubMed    
    Abstract available

  178. ZHANG Y, Xu L, Li L
    The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics.
    Medicine (Baltimore). 2023;102:e35135.
    PubMed    
    Abstract available

  179. VAN TRAPPEN P
    Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer.
    Best Pract Res Clin Obstet Gynaecol. 2023;90:102402.
    PubMed    
    Abstract available

  180. HUIYUN J, Jie D, Huan W, Yuebo Y, et al
    Prevalence and characteristics of cervical human papillomavirus genotypes and cervical lesions among 58630 women from Guangzhou, China.
    J Infect Public Health. 2023;16:1531-1536.
    PubMed    
    Abstract available

  181. WANG L, Chen G, Zhou C, Wu C, et al
    Expression and Significance of MTA2 and CPNE1 in Cervical Squamous Cell Carcinoma.
    Appl Immunohistochem Mol Morphol. 2023;31:569-573.
    PubMed    
    Abstract available

  182. BARTIN R, Delangle R, Mergui JL, Azais H, et al
    Impact of cervical excisional dimensions on endocervical margins status in adenocarcinoma in situ of the uterine cervix: A multicenter study from the FRANCOGYN group.
    J Gynecol Obstet Hum Reprod. 2023;52:102622.
    PubMed    
    Abstract available

  183. YUAN L, Dong X, Chen M, Yao L, et al
    A Vascular Centered Surgical Approach to Radical Hysterectomy: Laparoscopic Anatomy of Pelvic Vascular System Revisited.
    J Minim Invasive Gynecol. 2023;30:692.
    PubMed    
    Abstract available

  184. KISELEVA M, Lescot T, Selivanova SV, Fortin MA, et al
    Gold-Enhanced Brachytherapy by a Nanoparticle-Releasing Hydrogel and 3D-Printed Subcutaneous Radioactive Implant Approach.
    Adv Healthc Mater. 2023;12:e2300305.
    PubMed    
    Abstract available

  185. GROVER S, MacDuffie E, Nsingo M, Lei X, et al
    Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country Setting.
    JCO Glob Oncol. 2023;9:e2200397.
    PubMed    
    Abstract available

  186. MREMA AS, Ngoma M, Josiah C, Lugina E, et al
    HIV and Early Treatment Outcomes Among Women With Cervical Cancer Treated With Concurrent Chemoradiation in Tanzania.
    JCO Glob Oncol. 2023;9:e2200441.
    PubMed    
    Abstract available

  187. AMECK K, Kutha B, Jessica P, Rosemary M, et al
    Towards cervical cancer elimination in Zambia: Stakeholder views on lessons learned, progress to date, and future needs and priorities.
    Afr J Reprod Health. 2023;27:28-38.
    PubMed    
    Abstract available

  188. LI J, Wan C, Li X, Quan C, et al
    Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
    J Transl Med. 2023;21:647.
    PubMed    
    Abstract available

  189. HAN EJ, Choi EY, Jeon SJ, Lee SW, et al
    Piperlongumine induces apoptosis and autophagy via the PI3K/Akt/mTOR pathway in KB human cervical cancer cells.
    Food Chem Toxicol. 2023 Sep 19:114051. doi: 10.1016/j.fct.2023.114051.
    PubMed    
    Abstract available

  190. SASSENOU J, Ringa V, Zins M, Ozguler A, et al
    Combined influence of immigration status and income on cervical cancer screening uptake.
    Prev Med Rep. 2023;36:102363.
    PubMed    
    Abstract available

  191. YANG S, Zhang Z, Shen L
    Prognostic significance of C-reactive protein in patients with cervical cancer: a meta-analysis.
    Front Oncol. 2023;13:1232409.
    PubMed    
    Abstract available

  192. KURMYSHKINA OV, Dobrynin PV, Kovchur PI, Volkova TO, et al
    Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN.
    Front Immunol. 2023;14:1215607.
    PubMed    
    Abstract available

  193. ZHONG J, Huang L, Su M, Wu M, et al
    Ultrasound Microvessel Visualization in Cervical Cancer: Association Between Novel Ultrasound Techniques and Histologic Microvessel Densities.
    Ultrasound Med Biol. 2023 Sep 18:S0301-5629(23)00278.
    PubMed    
    Abstract available

  194. JODRY D, Obedin-Maliver J, Flowers L, Jay N, et al
    Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus-Related Cancers.
    J Low Genit Tract Dis. 2023;27:307-321.
    PubMed    
    Abstract available


  195. miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1 [Retraction].
    Cancer Manag Res. 2023;15:1009-1010.
    PubMed    
    Abstract available


  196. MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction].
    Onco Targets Ther. 2023;16:749-750.
    PubMed    
    Abstract available

  197. OOKO F, Mothiba T, Van Bogaert P, Wens J, et al
    Access to palliative care in patients with advanced cancer of the uterine cervix in the low- and middle-income countries: a systematic review.
    BMC Palliat Care. 2023;22:140.
    PubMed    
    Abstract available

  198. SUN L, Patel S, Fiorina C, Glass A, et al
    A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe.
    Eur J Health Econ. 2023 Sep 20. doi: 10.1007/s10198-023-01627.
    PubMed    
    Abstract available

  199. MUYA S, Ndumbalo J, Kutika Nyagabona S, Yusuf S, et al
    Feasibility and Clinical Acceptability of Automation-Assisted 3D Conformal Radiotherapy Planning for Patients With Cervical Cancer in a Resource-Constrained Setting.
    JCO Glob Oncol. 2023;9:e2300050.
    PubMed    
    Abstract available

  200. JIANG X, Zhang S, Fu Y, Yu H, et al
    Assembling High-Quality Lymph Node Clinical Target Volumes for Cervical Cancer Radiotherapy Using a Deep Learning-Based Approach.
    Curr Med Imaging. 2023 Sep 15. doi: 10.2174/1573405620666230915125606.
    PubMed    
    Abstract available

  201. SONG XC, Zhang H, Zhong S, Tan XJ, et al
    [Value of postoperative radiotherapy and analysis of prognostic factors in early-stage neuroendocrine carcinoma of cervix].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:680-690.
    PubMed    
    Abstract available

  202. RAJABI A, Dastmalchi N, Shokri N, Tayefeh-Gholami S, et al
    Expression Level of lncRNA CYTOR in Iranian Cervical Cancer Patients.
    Rep Biochem Mol Biol. 2023;12:120-126.
    PubMed    
    Abstract available

  203. ASARE M, Lanning BA, Montealegre JR, Akowuah E, et al
    Determinants of Low-Income Women's Participation in Self-Collected Samples for Cervical Cancer Detection: Application of the Theory of Planned Behavior.
    Community Health Equity Res Policy. 2023;44:65-76.
    PubMed    
    Abstract available

  204. ZHANG YH, Martin S, Liu H, Todor D, et al
    Utilizing a novel hybrid brachytherapy technique FINITO (Freehand Interstitial Needles in addition to Tandem and Ovoid) for locally advanced cervical cancer.
    Brachytherapy. 2023 Sep 16:S1538-4721(23)00082.
    PubMed    
    Abstract available

  205. LANDE PS, Adhao VS, Ambhore JP, Gaikwad KP, et al
    Anticancer action of naturally occurring emodin for the controlling of cervical cancer.
    Explor Target Antitumor Ther. 2023;4:690-698.
    PubMed    
    Abstract available

  206. SUN Z, Xiang D, Jiang J, Luo S, et al
    Cervical cancer heart metastasis presents as a giant mass.
    Eur Heart J Case Rep. 2023;7:ytad445.
    PubMed    


  207. SATO M, Tamauchi S, Yoshida K, Yoshihara M, et al
    Unclear tumor border in magnetic resonance imaging as a prognostic factor of squamous cell cervical cancer.
    Sci Rep. 2023;13:15392.
    PubMed    
    Abstract available

  208. YANG JY, Li Y, Shi J, Wan SM, et al
    CNIH4 governs cervical cancer progression through reducing ferroptosis.
    Chem Biol Interact. 2023 Sep 14:110712. doi: 10.1016/j.cbi.2023.110712.
    PubMed    
    Abstract available

  209. WU M, Ye M
    Transcription factor Dp-1 knockdown downregulates thymidine kinase 1 expression to protect against proliferation and epithelial-mesenchymal transition in cervical cancer.
    Funct Integr Genomics. 2023;23:301.
    PubMed    
    Abstract available

  210. ERKIN O
    How did adult women's fear of COVID-19 affect their attitudes toward cervical cancer screening? An example of Turkey.
    Afr J Reprod Health. 2023;27:77-87.
    PubMed    
    Abstract available

  211. CHEN H, Ren S, Wan H, Wei W, et al
    DUSP1 regulates the JAK2/STAT3 signaling pathway through targeting miR-21 in cervical cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2023;69:40-44.
    PubMed    
    Abstract available

  212. ZHAO X, Li S, Wen J, Li Y, et al
    The expression and clinical value of LRP11, FUBP1 and TET1 in cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2023;69:80-84.
    PubMed    
    Abstract available


  213. A vaccine against the cervical-cancer virus shows its prowess.
    Nature. 2023;621:447.
    PubMed    


  214. HE L, Li P, Zhang H
    Clinical significance of MATN1-AS1 as ceRNA of Mir-200b in tissues and serum of patients with cervical cancer.
    Sci Rep. 2023;13:15336.
    PubMed    
    Abstract available

  215. HU Y, Jin Y, Wang D, Luo Y, et al
    Observation of hemostatic effectiveness and safety of ultrasound-CT guided 3D intracavitary and interstitial brachytherapy in the treatment of larger cervical cancer with bleeding: A retrospective study.
    Medicine (Baltimore). 2023;102:e34904.
    PubMed    
    Abstract available

  216. BERTOLAZZI MA, Genta MLND, Carvalho F, Baracat EC, et al
    Successful Pre-Treatment Ovarian Fresh Tissue Transplantation in a Cervical Cancer Patient Undergoing Radiation Therapy: A Case Report.
    Cureus. 2023;15:e43472.
    PubMed    
    Abstract available

  217. FALCARO M, Sasieni P, Castanon A
    audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening.
    Inform Med Unlocked. 2023;38:101182.
    PubMed    
    Abstract available

  218. MINCHEW LA, Cesario SK, Richmond MM, Mbango CM, et al
    Examining the Burden of Self-Blame Attribution Among Women With Cervical Cancer.
    J Holist Nurs. 2023 Sep 14:8980101231194218. doi: 10.1177/08980101231194218.
    PubMed    
    Abstract available

  219. GRACIA M, Rodriguez E, Diestro MD, Spagnolo E, et al
    Impact of the Covid-19 pandemic on the management of gynecologic cancer: a Spanish survey. Observational, multicenter study.
    BMC Womens Health. 2023;23:488.
    PubMed    
    Abstract available

  220. SHUKLA S, Vishwakarma C, Sah AN, Ahirwar S, et al
    Smartphone-based fluorescence spectroscopic device for cervical precancer diagnosis: a random forest classification of in vitro data.
    Appl Opt. 2023;62:6826-6834.
    PubMed    
    Abstract available

  221. MIRAHMAD A, Hafez Ghoran S, Alipour P, Taktaz F, et al
    Oliveria decumbens Vent. (Apiaceae): Biological screening and chemical compositions.
    J Ethnopharmacol. 2024;318.
    PubMed    
    Abstract available

  222. CHU B, Dong J, Chen Y, Ru X, et al
    Triage Value of Cervical Exfoliated Cell DNA Ploidy Analysis in Cervical High-Risk Human Papillomavirus-Positive Women.
    J Low Genit Tract Dis. 2023;27:331-336.
    PubMed    
    Abstract available

  223. LETAFATI A, Sakhavarz T, Khosravinia MM, Ardekani OS, et al
    Exploring the correlation between progression of human papillomavirus infection towards carcinogenesis and nutrition.
    Microb Pathog. 2023;183:106302.
    PubMed    
    Abstract available

  224. CHI Y, Shi L, Lu S, Cui H, et al
    Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
    J Ethnopharmacol. 2024;318.
    PubMed    
    Abstract available

  225. FUJITA Y, Fukuda Y, Sanuki F, Irei I, et al
    Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis.
    Head Neck Pathol. 2023;17:658-672.
    PubMed    
    Abstract available

  226. ING BI, Scott ME, Lentz SE
    Opportunities Missed: Cervix Cancer Screening Failures in Women Aged 65 and Older.
    J Low Genit Tract Dis. 2023;27:337-342.
    PubMed    
    Abstract available

  227. ISNARD C, Chanal J, Bergeron C, Aynaud O, et al
    High-grade cervical squamous intraepithelial lesions in female partners of men with high-grade penile squamous intraepithelial lesions: a monocentric retrospective study.
    Br J Dermatol. 2023;189:485-486.
    PubMed    


  228. ECE GT, Pira D, Bodur GL
    Prevalence and distribution of high-risk Human Papillomavirus in Western Turkiye between 2019 and 2022.
    Acta Microbiol Immunol Hung. 2023;70:252-257.
    PubMed    
    Abstract available

  229. KULKARNI A, Covens A, Durand N, Ghorab Z, et al
    Role of HPV in the Prediction of Persistence/Recurrence After Treatment for Cervical Precancer.
    J Obstet Gynaecol Can. 2023;45:102171.
    PubMed    
    Abstract available

  230. FERNANDES FP, Cambui RAG, Soares JLDS, Reis ECD, et al
    Cervical carcinoma induces NLRP3 inflammasome activation and IL-1ss release in human peripheral blood monocytes affecting patients' overall survival.
    Clin Transl Oncol. 2023;25:3277-3286.
    PubMed    
    Abstract available

  231. LI C, Hua K
    Single-cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions.
    Cancer Commun (Lond). 2023;43:1055-1058.
    PubMed    


  232. KEIM-MALPASS J, Vavolizza RD, Cohn WF, Kennedy EM, et al
    Cancer Screening and Treatment Delays During the COVID-19 Pandemic and the Role of Health Literacy in Care Re-engagement: Findings from an NCI-Designated Comprehensive Cancer Center sample.
    J Cancer Educ. 2023;38:1405-1412.
    PubMed    
    Abstract available

  233. XIAO X, Yan L, Yang X, Zhou Z, et al
    Optical Coherence Tomography Can Reduce Colposcopic Referral Rates in Patients With High-Risk Human Papillomavirus.
    J Low Genit Tract Dis. 2023;27:324-330.
    PubMed    
    Abstract available

  234. TAMMARO A, Kulakowska KA, Adebanjo GAR, Parisella FR, et al
    Oral and genital mucosa lesions in patients with COVID-19: a multicentric case series.
    Int J Dermatol. 2023;62:e554-e556.
    PubMed    


  235. MACKINNON KM, Risica PM, von Ash T, Scharf AL, et al
    Barriers and motivators to women's cancer screening: A qualitative study of a sample of diverse women.
    Cancer. 2023;129.
    PubMed    
    Abstract available

  236. KIR G, Gunel H, Cicek T, Seneldir H, et al
    Immediate histopathologic correlation in Turkish population with negative cytology and high-risk human papillomavirus positivity: A retrospective analysis of high-risk human papillomavirus genotype and stratified by age.
    Diagn Cytopathol. 2023;51:605-611.
    PubMed    
    Abstract available

  237. MARCHAND G, Taher Masoud A, Abdelsattar A, King A, et al
    Systematic Review and Meta-analysis of laparoscopic radical hysterectomy vs. Robotic assisted radical hysterectomy for early stage cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:190-202.
    PubMed    
    Abstract available

  238. PRAISS AM, Allison D, Tessier-Cloutier B, Flynn J, et al
    Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study.
    Gynecol Oncol. 2023;176:147-154.
    PubMed    
    Abstract available

  239. AGUSTI N, Viveros-Carreno D, Mora-Soto N, Ramirez PT, et al
    Diagnostic accuracy of sentinel lymph node frozen section analysis in patients with early-stage cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;177:157-164.
    PubMed    
    Abstract available

  240. LEE HC, Jeong JW, Lee JH, Kim SH, et al
    High-dose (60 Gy) intensity-modulated radiotherapy with concurrent weekly cisplatin followed by intracavitary radiation in locally advanced cervical cancer: A phase II prospective clinical trial.
    Gynecol Oncol. 2023;177:142-149.
    PubMed    
    Abstract available

  241. WANG J, Edvardsson H, Strander B, Andrae B, et al
    Long-term follow-up of cervical cancer incidence after normal cytological findings.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34723.
    PubMed    
    Abstract available

  242. REIJNTJES B, Eising M, Kleppe M, Geuken E, et al
    The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Int J Gynaecol Obstet. 2023;163:140-147.
    PubMed    
    Abstract available

  243. HAMAR B, Teutsch B, Hoffmann E, Hegyi P, et al
    Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
    Int J Gynaecol Obstet. 2023;163:31-43.
    PubMed    
    Abstract available

  244. TURCO LC, Pedone Anchora L, Scambia G, Ferrandina G, et al
    Response to: Correspondence on "Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery" by Yuce Sari et al.
    Int J Gynecol Cancer. 2023;33:1491-1492.
    PubMed    


  245. YUCE SARI S, Bay M, Gultekin M
    Correspondence on 'Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery' by Turco et al.
    Int J Gynecol Cancer. 2023;33:1490.
    PubMed    


  246. NAKISIGE C, de Fouw M, Kabukye J, Sultanov M, et al
    Artificial intelligence and visual inspection in cervical cancer screening.
    Int J Gynecol Cancer. 2023 Sep 4:ijgc-2023-004397. doi: 10.1136/ijgc-2023-004397
    PubMed    
    Abstract available

  247. MICHAAN N, Wenkert A, Even-Sapir E, Kerzhner K, et al
    Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
    Int J Gynecol Cancer. 2023 Sep 1:ijgc-2023-004703. doi: 10.1136/ijgc-2023-004703
    PubMed    
    Abstract available

  248. SALVO G, Flores Legarreta A, Ramalingam P, Jhingran A, et al
    Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
    Int J Gynecol Cancer. 2023;33:1359-1369.
    PubMed    
    Abstract available

  249. PLAIKNER A, Siegler K, Hertel H, Jacob A, et al
    Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
    Int J Gynecol Cancer. 2023 Sep 11:ijgc-2023-004669.
    PubMed    
    Abstract available

  250. BIZZARRI N, Russo L, Dolciami M, Zormpas-Petridis K, et al
    Radiomics systematic review in cervical cancer: gynecological oncologists' perspective.
    Int J Gynecol Cancer. 2023 Sep 15:ijgc-2023-004589.
    PubMed    
    Abstract available

  251. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
    First international proficiency study on human papillomavirus testing in cervical cancer screening.
    J Clin Virol. 2023;167:105581.
    PubMed    
    Abstract available

  252. EINSTEIN MH, Zhou N, Gabor L, Sahasrabuddhe VV, et al
    Primary Human Papillomavirus Testing and Other New Technologies for Cervical Cancer Screening.
    Obstet Gynecol. 2023 Sep 14. doi: 10.1097/AOG.0000000000005393.
    PubMed    
    Abstract available

  253. VOLESKY-AVELLANEDA KD, Laurie C, Tsyruk-Romano O, El-Zein M, et al
    Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Sep 14. doi: 10.1097/AOG.0000000000005370.
    PubMed    
    Abstract available

  254. LIANG H, Luo R, Chen X, Zhao Y, et al
    [Retracted] miR?187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2023;50:195.
    PubMed    
    Abstract available

  255. SAMADI M, Mokhtari-Azad T, Nejati A, Norooz-Babaei Z, et al
    The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
    BMC Cancer. 2023;23:803.
    PubMed    
    Abstract available

  256. CHETTY-SEBASTIAN D, Assounga AG
    Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
    BMC Cancer. 2023;23:830.
    PubMed    
    Abstract available

  257. O'DOWD EL, Merriel SWD, Cheng VWT, Khan S, et al
    Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.
    BMC Cancer. 2023;23:820.
    PubMed    
    Abstract available

  258. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:819.
    PubMed    
    Abstract available

  259. HE C, Pei C, Ma J
    Developing an evaluation indicators of health literacy for cervical cancer among Chinese women: a modified Delphi method study.
    BMC Cancer. 2023;23:863.
    PubMed    
    Abstract available

  260. WANG F, Song S, Guo B, Li Y, et al
    Increased TCP11 gene expression can inhibit the proliferation, migration and promote apoptosis of cervical cancer cells.
    BMC Cancer. 2023;23:853.
    PubMed    
    Abstract available

  261. ZHU M, Li X, Feng Y, Jia T, et al
    Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study.
    BMC Cancer. 2023;23:845.
    PubMed    
    Abstract available

  262. URQUHART G, Maclennan SJ, Guntupalli AM
    Is there an association between intimate partner violence and the prevalence of cervical cancer screening in Jordan?
    PLoS One. 2023;18:e0290678.
    PubMed    
    Abstract available

  263. SUNDARA RAJAN R S, Thomas J, Francis D, Daniel EC, et al
    Effective gene delivery using size dependant nano core-shell in human cervical cancer cell lines by magnetofection.
    PLoS One. 2023;18:e0289731.
    PubMed    
    Abstract available

  264. ODEH HI, Al-Badi SR, Karima B, Saeed TA, et al
    Exploring the prevalence of Human Papillomavirus (HPV) genotypes in PAP smear samples of women in northern region of United Arab Emirates (UAE): HPV Direct Flow CHIP system-based pilot study.
    PLoS One. 2023;18:e0286889.
    PubMed    
    Abstract available

  265. WANG S, Wang Y, Zhuang J, Wu Y, et al
    Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.
    PLoS One. 2023;18:e0290905.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;